TCIM
ONCE

TIAA CREF Investment Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

TIAA CREF Investment Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6.81M Sell
59,811
-1,497
-2% -$110K ﹤0.01% 1261
2018
Q4 		$2.4M Sell
61,308
-1,413
-2% -$61.3K ﹤0.01% 1847
2018
Q3 		$3.42M Sell
62,721
-6,064
-9% -$415K ﹤0.01% 1834
2018
Q2 		$5.69M Buy
68,785
+4,720
+7% +$364K ﹤0.01% 1508
2018
Q1 		$4.27M Sell
64,065
-10,787
-14% -$623K ﹤0.01% 1660
2017
Q4 		$3.85M Sell
74,852
-4,105
-5% -$295K ﹤0.01% 1766
2017
Q3 		$7.04M Buy
78,957
+16,477
+26% +$1.25M ﹤0.01% 1402
2017
Q2 		$3.73M Buy
62,480
+10,544
+20% +$589K ﹤0.01% 1783
2017
Q1 		$2.77M Sell
51,936
-3,340
-6% -$198K ﹤0.01% 1942
2016
Q4 		$2.76M Sell
55,276
-1,308
-2% -$70.1K ﹤0.01% 2003
2016
Q3 		$3.4M Buy
56,584
+4,370
+8% +$252K ﹤0.01% 1855
2016
Q2 		$2.67M Buy
52,214
+25,086
+92% +$1.07M ﹤0.01% 1948
2016
Q1 		$801K Sell
27,128
-24,870
-48% -$784K ﹤0.01% 2597
2015
Q4 		$2.36M Buy
51,998
+14,010
+37% +$734K ﹤0.01% 2045
2015
Q3 		$1.58M Sell
37,988
-39,207
-51% -$2.05M ﹤0.01% 2285
2015
Q2 		$4.65M Buy
77,195
+64,234
+496% +$4.25M ﹤0.01% 1735
2015
Q1 		$1M Buy
+12,961
New +$746K ﹤0.01% 2620

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

TIAA CREF Investment Management's ONCE Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 2.4% in Q1 2019, selling an estimated $110K and leaving 59,811 shares worth $6.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

TIAA CREF Investment Management first reported a position in ONCE in Q1 2015 and has held it in 17 quarters since. The position peaked at $7.04M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • TIAA CREF Investment Management held 59,811 shares of Spark Therapeutics, Inc. Common Stock worth $6.81M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,497 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $110K.
  • Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1261 holding.
  • TIAA CREF Investment Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and has held it in 17 quarters since.
  • TIAA CREF Investment Management's Spark Therapeutics, Inc. Common Stock position peaked at $7.04M in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.